Author:
Debiec-Rychter M.,Dumez H.,Judson I.,Wasag B.,Verweij J.,Brown M.,Dimitrijevic S.,Sciot R.,Stul M.,Vranck H.,Scurr M.,Hagemeijer A.,Van Glabbeke M.,van Oosterom A.T.
Reference19 articles.
1. Association of KIT Exon 9 mutations with nongastric primary site and aggressive behaviour;Antonescu;Clin. Cancer Res.,2003
2. Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region;Chan;Mol. Cell Biology,2003
3. Imatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors;Chen;Int. J. Cancer,2003
4. Efficacy and safety of Imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;New Eng. J. Med.,2002
5. Mechanisms of resistance to imatinib mesylate (IM) in advanced gastrointestinal stromal tumot (GIST);Fletcher;Proc. Am. Soc. Clin. Oncol.,2003
Cited by
404 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献